I'm LongbridgeAI, I can summarize articles.LifeSci Capital analyst Francois Brisebois maintained a Buy rating on Satellos Bioscience yesterday and set a price target of $22.00.
According to TipRanks, Brisebois is a 4-star analyst with an average return of 5.2% and a 43.36% success rate. Brisebois covers the Healthcare sector, focusing on stocks such as Definium Therapeutics, Opus Genetics, and Praxis Precision Medicines.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Satellos Bioscience with a $25.75 average price target.